*Dr. Seetheraman is not licensed to practice law. His activities are directly supervised by members of the firm licensed to practice law.
Sai Seetharaman assists in patent preparation, prosecution conducting patentability and freedom-to-operate searches in order to develop a global IP strategy for the client. Dr. Seetharaman’s practice areas include molecular biology, biophysics, organic synthesis, and biochemistry. He has experience in the preparation and prosecution of both US and foreign patent applications involving cancer therapy, immunotherapy, antibiotics, antibody engineering, site-specific conjugation, structure-based drug design and pharmaceutical formulations. Sai has also assisted extensively in patent litigation.
Dr. Seetharaman has had previous patent prosecution experience as a patent agent at McCarter & English and Hamilton Brook Smith Reynolds, where he has assisted in filing and managing the worldwide patent portfolios of emerging and mature pharmaceutical companies with technologies spanning multiple therapeutic areas including cancer, neurodegenerative diseases, inflammation, diabetes and auto-immune disorders. Specifically, Sai has managed the worldwide patent portfolio of a mature pharmaceutical company, and has worked extensively with IP professionals across different jurisdictions. He has also worked directly with scientists to help protect their ideas.
Sai also has experience in working in-house as a patent agent in a pharmaceutical company that develops novel therapies for the treatment of cancer. Additionally, he interned at the Yale Office of Corporate Research, where he performed technical analysis, conducted prior art searches, interacted directly with inventors, prepared written reports with recommendations regarding patentability, and assisted in drafting patent claims.
Before becoming a patent agent, Dr. Seetharaman was a Howard Hughes Medical Institute (HHMI) Fellow at Yale University in the laboratory of Nobel Laureate, Thomas A. Steitz where he determined multiple protein/RNA crystal structures, performed biophysical and structural characterization of bacterial ribosome in complex with different antibiotics, and developed a model system for studying the process of ribosome stalling and rescue which laid the framework for the development of several therapeutic agents to target multiple drug resistance (MDR) in bacteria. His technical experience includes characterizing proteins, nucleic acids and small molecule drugs using macromolecular x-ray crystallography, nuclear magnetic resonance spectroscopy, surface plasmon resonance (Biacore), and mass spectrometry. Sai has had a very productive and fulfilling research career of over 10 years where his findings were published in top-ranked international scientific journals.
Sai has been the recipient of many awards and honors and is fluent in Sanskrit, Hindi, Tamil, Telugu and Malayalam.